PFE News 30.86 04/21/2014 21:44:10 Pfizer Inc (PFE)

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Pfizer Inc (PFE) 30.86 $PFE

Netflix Jumps on Earnings; Ford Taps Next CEO
Jeremy Bowman, The Motley Fool - Motley Fool - 43 mins ago
Stocks didn't miss a beat coming back from the long weekend, as all three indexes added to last week's gains today. As earnings season heats up this week, investors seem to be encouraged by mostly upside reports from the financial sector last week...

Dow Climbs As Pharma Stocks Jump, but Will Drug M&A Hurt UnitedHealth?
Dan Caplinger, The Motley Fool - Motley Fool - 1 hr 39 mins ago
The Dow Jones Industrials rose more than 40 points Monday as investors continued to ride the wave of enthusiasm that has accompanied the beginning of earnings season. Leading the way higher for the Dow were Pfizer and Merck , which gained 2%...

Valeant to bid for Botox maker Allergan
By KEN SWEET and MATTHEW PERRONE - AP - 2 hrs 35 mins ago
NEW YORK (AP) — Valeant Pharmaceuticals has teamed up with activist investor Bill Ackman in a bid for Botox maker Allergan that could be worth about $40 billion.

Pfizer may make cancer play
at Investor's Business Daily - Mon Apr 21, 5:42PM CDT
AstraZeneca's (AZN) pipeline of cancer drugs may draw Pfizer (PFE) back for another look after its earlier $101 bil proposed purchase was rejected, reports said. AstraZeneca has a line of experimental drugs called immunotherapies that show promise of...

Pfizer, Inc. Rebuffed: Is AstraZeneca plc Worth Another Try?
Stephen D., Simpson,, The Motley Fool - Motley Fool - Mon Apr 21, 5:30PM CDT
Big-time pharma mergers have had a mixed track record, with large combinations often leading to significant cost reductions (and firings) in sales and administration but at the cost of large disruptions to R&D. Pfizer is apparently not afraid...

The Biggest Biotech Wins of the Week
Cory Renauer, The Motley Fool - Motley Fool - Mon Apr 21, 5:30PM CDT
The iShares Nasdaq Biotechnology Index finally put up some gains last week as some big names released great news. It looks like GlaxoSmithKline might have an oral psoriasis candidate. Hemophilia giant Baxter might be adding another therapy to...

Most active New York Stock Exchange-traded stocks
AP - Mon Apr 21, 5:02PM CDT
NEW YORK (AP) — A look at New York Stock Exchange 10 most-active stocks at the close of trading:

Final Glance: Pharmaceuticals companies
AP - Mon Apr 21, 5:02PM CDT
NEW YORK (AP) — Shares of some top pharmaceuticals companies were up at the close of trading:

Pfizer Set to Possibly Pullback After Yesterday's Rally of 2.02%
Comtex SmarTrend(R) - Mon Apr 21, 3:45PM CDT
Pfizer (NYSEFE) traded in a range yesterday that spanned from a low of $30.40 to a high of $30.94. Yesterday, the shares gained 2.0%, which took the trading range above the 3-day high of $30.40 on volume of 30.2 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.

SmarTrend Watching for Potential Pullback in Shares of Pfizer After 2.02% Gain
Comtex SmarTrend(R) - Mon Apr 21, 3:44PM CDT
Pfizer (NYSEFE) traded in a range yesterday that spanned from a low of $30.40 to a high of $30.94. Yesterday, the shares gained 2.0%, which took the trading range above the 3-day high of $30.40 on volume of 30.2 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.

Supreme Court Denies Teva's Request - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Apr 21, 3:35PM CDT
The U.S. Supreme Court denied Teva's appeal of a decision from the U.S. Court of Appeals for the Federal Circuit that invalidated the claim of U.S. Patent 5,800,808 covering Teva's relapsing-remitting multiple sclerosis (RRMS) product, Copaxone 20mg/mL.

Is Pfizer Eyeing AstraZeneca? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Apr 21, 3:30PM CDT
According to a report by UK's Sunday Times, Pfizer is looking to acquire AstraZeneca for about $101 billion.

Stocks Rise In Weak Volume; Pfizer Paces Drugmakers
at Investor's Business Daily - Mon Apr 21, 3:27PM CDT
Stocks rose in slow volume Monday, with the S&P 500 rising for a fifth straight session, ahead of key earnings reports. The Nasdaq advanced 0.6%, while the S&P 500 rose 0.3% and the Dow Jones industrials edged up 0.2% each. Volume was sharply lower...

Stocks Up, But Slow Trade Points To Lack Of Big Money
at Investor's Business Daily - Mon Apr 21, 2:00PM CDT
Stocks rose in slow volume Monday afternoon, showing scant evidence that the big-money players were back from the holiday. The Nasdaq advanced 0.5%, while the S&P 500 and the Dow Jones industrial added 0.3% each. Volume was running sharply lower vs....

Kaplan Fox Announces $190 Million Settlement with Pfizer, Inc. and Warner-Lambert Co.
PR Newswire - Mon Apr 21, 1:42PM CDT
Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) announces a $190 Million settlement, subject to court approval, with Pfizer, Inc. and Warner-Lambert Co. ("Defendants" in In re Neurontin Antitrust Litigation, No. 02-1390, pending in the District of New Jersey.

Pfizer's Missed Megadeal Sparks the Dow's Rise
Dan Carroll, The Motley Fool - Motley Fool - Mon Apr 21, 1:37PM CDT
The market opened the week on an upbeat note, with the major stock indices all modestly on the upswing. The Dow Jones Industrial Average  was up more than 45 points as of 2:35 p.m. EDT. Big Pharma's Pfizer has led the Dow's gain so far today,...

Warfarin's Loss is Johnson & Johnson's Gain
Todd Campbell, The Motley Fool - Motley Fool - Mon Apr 21, 1:30PM CDT
Warfarin has long been doctor's go-to medicine for guarding against blood clots in post-operative or cardiovascular disease patients. However, an important shift that began in 2010 is having a profound effect on warfarin's dominance -- the approval...

Dow Today: Pfizer (PFE) Higher
at The Street - Mon Apr 21, 1:00PM CDT
The Dow component leading the way higher looks to be Pfizer (NYSE: PFE ), which is sporting a 60-cent gain (+2%) bringing the stock to $30.85.

Why Pfizer (PFE) Stock Is Up Today
at The Street - Mon Apr 21, 12:45PM CDT
Pfizer (PFE) rose Monday amid reports that the U.S. pharmaceutical giant has approached British rival AstraZeneca (AZN) about a $101 billion takeover. Britain's Sunday Times cited senior investment bankers and other sources within the industry to...
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Isar’s Nova Scotia Pad Build Gives MAXQ a Real Test

Updated Category News Views 121

Concrete work is where space ambition stops being a brochure. Isar Aerospace has taken operational responsibility for its dedicated launch infrastructure at Spaceport Nova Scotia, and construction is beginning on the Canadian launch pad it will use. For Maritime Launch Services, this is the sort of update that deserves more than the usual starry-eyed applause. A Site...

Continue Reading
Employer Ghosting Is a Quiet Talent-Cost Problem Today

Updated Category News Views 173

Silence is cheap right up until a company needs talent again. Then the unanswered email, abandoned interview loop, or vanished promise of next steps comes back with a price tag—maybe not neatly labeled in a quarterly filing, but real all the same. LiveCareer’s April 14, 2026 survey of 1,008 employed U.S. adults lands on an uncomfortable point: candidates remember...

Continue Reading
WaterField’s Nova Case Bets on Better Handheld Carry

Updated Category News Views 211

Tiny handhelds have spawned a surprisingly fussy luggage problem: protection without the clown-show aesthetic. WaterField Designs is taking a clean swing at that with a custom case for the Retroid Pocket Nova, a sleeve-like carrier built around the device rather than some generic pouch that leaves everything rattling around inside. This is not a market-moving corporate...

Continue Reading
ModuleMD Takes Allergy EHR AI Beyond the Usual Hype Cycle

Updated Category News Views 210

Allergy Workflows Are Where This Has to Earn Its Keep Allergy clinics do not need another shiny dashboard clogging up a workstation. They need less typing, fewer handoffs, cleaner documentation, and fewer administrative chores slipping through the cracks while a packed day keeps moving. That is the practical lens for ModuleMD's ACAAI 2026 presentation in Phoenix: not...

Continue Reading
CCAPP Holiday Training Targets Seasonal Recovery Strain

Updated Category News Views 126

December cheer has a nasty habit of hiding the people barely holding themselves together. CCAPP’s upcoming virtual workshop, Hope for the Holidays: Understanding Depression, Stress & Resilience During the Holiday Season, takes that uncomfortable reality seriously rather than treating it like a seasonal footnote. For behavioral health workers supporting people in...

Continue Reading
Kyverna Probe Reopens IPO Disclosure Questions for Investors

Updated Category News Views 123

Clinical-trial caveats have a nasty habit of becoming shareholder headaches years later. Kyverna Therapeutics is back in that uncomfortable zone after Kahn Swick & Foti said it has opened an investigation into whether the company’s officers and directors breached fiduciary duties or otherwise violated state or federal law. For holders of KYTX, this is not a verdict and...

Continue Reading
D-Wave Investors Face a December 15 Lead Plaintiff Clock

Updated Category News Views 175

August Put the Story Under a Harsh Light Two ugly August trading sessions are doing a lot of work in the case now confronting D-Wave Quantum. The company sits in a field that attracts big dreams, big headlines, and, frankly, plenty of investor imagination. But imagination does not cushion a portfolio when expectations crack. The lawsuits concern people who bought or...

Continue Reading
Human Frontier Mission Puts AI Research on Display

Updated Category News Views 95

A laboratory notebook is about to become the real product in this AI experiment. Human Frontier Mission, or HFM, says it will launch globally on Nov. 24, opening a research program where domain specialists frame scientific and engineering problems while autonomous AI agents develop and test possible answers. The unusual bit is not merely handing models difficult work. It...

Continue Reading
Fluence Investors Face a November 27 Litigation Clock

Updated Category News Views 157

Six calendar squares are all that separate eligible Fluence investors from the November 27, 2026 lead-plaintiff deadline. That is not much time to locate trade confirmations, calculate losses, and decide whether taking a larger role in a securities case makes sense. The lawsuit is not a verdict, and anybody pretending otherwise is selling smoke. But the underlying...

Continue Reading
QuidelOrtho Faces Fresh Scrutiny Over Savanna Claims

Updated Category News Views 203

A diagnostic launch can turn into a corporate migraine with frightening speed, and QuidelOrtho is staring at exactly that sort of mess. Kahn Swick & Foti said on November 20, 2026, that it has begun investigating whether QuidelOrtho officers or directors breached fiduciary duties or otherwise violated state or federal law. This is not a finding of wrongdoing. It is an...

Continue Reading

Top 5 Most Recently Viewed Articles

Breaker’s TruSend™: A Game Changer in Email Marketing

Updated Category News Views 142

Breaker’s TruSend™: A Game Changer in Email Marketing In the fast-evolving world of marketing, email continues to hold its ground as a vital communication tool. Breaker has recognized the challenges marketers face with fragmented tech stacks and has introduced TruSend™, a robust email distribution platform. This innovation streamlines the email marketing process,...

Continue Reading
DigiKey and Qorvo Collaborate to Enhance Global Distribution

Updated Category News Views 151

DigiKey and Qorvo Forge Strategic Distribution Partnership DigiKey, a prominent global distributor known for its vast selection of technical components and automation products, has entered into a vital distribution agreement with Qorvo®, a leader in connectivity and power solutions. This collaboration aims to boost the availability and delivery speed of Qorvo's...

Continue Reading
Lloyds Bank's Financial Insights for 2025: A Comprehensive Review

Updated Category News Views 345

Overview of Lloyds Bank plc's 2025 Half-Year Results Lloyds Bank plc, a prominent player in the financial services sector, has released its half-year results for 2025, demonstrating resilience and strategic agility. As a member of the Lloyds Banking Group, it continues to show its commitment to delivering value to its stakeholders and customers. Key Financial Highlights...

Continue Reading
Advansor's Latest CO2 Enclosure Solutions Revolutionize Climate Control

Updated Category News Views 97

Advansor Introduces a New Range of CO2 Enclosures Advansor, a leading name in climate solutions, has recently unveiled an innovative line of CO2 enclosures tailored for supermarkets, cold storage facilities, and industrial applications. These enclosures are designed to simplify on-site installations and offer flexible options for outdoor placement. This groundbreaking...

Continue Reading
LG Innotek's Revolutionary Automotive AP Module Enhances Mobility

Updated Category News Views 220

LG Innotek's Innovative Entry into Automotive Semiconductor Market LG Innotek has taken a significant step into the automotive semiconductor component market with the launch of its Automotive Application Processor Module (AP Module). This move comes in response to a growing demand for sophisticated automotive technologies, particularly in the realm of Advanced Driver...

Continue Reading